Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohort.

ESMO Open · 2023 · PMC10024130 · PMID 36753993

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

a strong trendP = 0.052so close (0.05 < p ≤ 0.1)

Whereas we did not observe a significant difference in PFS [CHT: 3.0 months (95% CI 1.4-4.6 months) versus nCHT: 3.2 months (95% CI 2.8-3.6 months), P = 0.725], there was a strong trend towards longer OS in the CHT group [CHT: 15.5 months (95% CI 8.0-23.0 months) versus nCHT: 5.3 months (95% CI 0-12.5 months), P = 0.052] ( Figure 1 C).

also in 868 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.